Dr Andrew Grace (Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK) spoke to us at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, and gave us a quick rundown of his Year in Review presentation on implantable cardioverter defibrillators (ICDs) and subcutaneous ICDs.
Speaker’s Disclosures: Andrew Grace has nothing to declare in relation to this video interview.
1. Year in Review: Cardiac Implantable Devices – Implantable Cardioverter Defibrillators/Subcutaneous Implantable Cardioverter Defibrillators (0:09)
2. How did the debate go on non-contact mapping? (1:18)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Devices
Mandeep Mehra, ESC 2022: HeartMate 3™ left ventricular assist device for heart failure, the MOMENTUM 3 study 2- and 5-year results
Following its positive 2-year results, the MOMENTUM 3 study in patients with heart failure was extended to assess 5-year outcomes of the HeartMate 3™ left ventricular assist device. In this touchCARDIO interview, we speak with Dr Mandeep Mehra (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) to discuss the MOMENTUM 3 study and […]
Mandeep Mehra, ESC 2022: Advances in left ventricular assist devices (LVADs) for heart failure and the advantages of the HeartMate 3™ LVAD
Left ventricular assist devices (LVADs) are utilised to treat patients with heart failure, the HeartMate 3™ being an example. In this touchCARDIO interview, we speak with Dr Mandeep Mehra (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) to discuss the advances in LVADs and the advantages the HeartMate 3™ (HM3) LVAD holds over […]
Erwan Donal, ESC 2022: The TriClip bRIGHT study for symptomatic patients with severe tricuspid regurgitation
The bRIGHT study aimed to evaluate the safety and effectiveness of the TriClip device in symptomatic patients with severe tricuspid regurgitation. In this touchCARDIO interview, we speak with Professor Erwan Donal (University Hospital of Rennes, Rennes, France) to discuss tricuspid transcatherter edge-to-edge repair, the difficulty in patient selection and the purpose and conclusions of the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!